• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞衍生细胞外囊泡在再生医学中的治疗进展。

Therapeutic Advances of Stem Cell-Derived Extracellular Vesicles in Regenerative Medicine.

机构信息

Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application, Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang 212013, Jiangsu, China.

出版信息

Cells. 2020 Mar 13;9(3):707. doi: 10.3390/cells9030707.

DOI:10.3390/cells9030707
PMID:32183102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7140663/
Abstract

Extracellular vesicles (EVs), which are the main paracrine components of stem cells, mimic the regenerative capacity of these cells. Stem cell-derived EVs (SC-EVs) have been used for the treatment of various forms of tissue injury in preclinical trials through maintenance of their stemness, induction of regenerative phenotypes, apoptosis inhibition, and immune regulation. The efficiency of SC-EVs may be enhanced by selecting the appropriate EV-producing cells and cell phenotypes, optimizing cell culture conditions for the production of optimal EVs, and further engineering the EVs produced to transport therapeutic and targeting molecules.

摘要

细胞外囊泡(EVs)是干细胞的主要旁分泌成分,模拟了这些细胞的再生能力。在临床前试验中,通过维持干细胞特性、诱导再生表型、抑制细胞凋亡和调节免疫,干细胞来源的 EVs(SC-EVs)已被用于治疗各种形式的组织损伤。通过选择合适的产生 EV 的细胞和细胞表型、优化细胞培养条件以产生最佳 EV 以及进一步对产生的 EV 进行工程改造以运输治疗和靶向分子,可以提高 SC-EVs 的效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/547e32877ad3/cells-09-00707-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/69e5f97b14d7/cells-09-00707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/8d0d7d91617c/cells-09-00707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/325335a05512/cells-09-00707-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/547e32877ad3/cells-09-00707-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/69e5f97b14d7/cells-09-00707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/8d0d7d91617c/cells-09-00707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/325335a05512/cells-09-00707-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ee/7140663/547e32877ad3/cells-09-00707-g004.jpg

相似文献

1
Therapeutic Advances of Stem Cell-Derived Extracellular Vesicles in Regenerative Medicine.干细胞衍生细胞外囊泡在再生医学中的治疗进展。
Cells. 2020 Mar 13;9(3):707. doi: 10.3390/cells9030707.
2
Stem Cells-Derived Extracellular Vesicles: Potential Therapeutics for Wound Healing in Chronic Inflammatory Skin Diseases.干细胞衍生的细胞外囊泡:用于治疗慢性炎症性皮肤病创面愈合的潜在疗法。
Int J Mol Sci. 2021 Mar 19;22(6):3130. doi: 10.3390/ijms22063130.
3
Stem cell- derived extracellular vesicles as new tools in regenerative medicine - Immunomodulatory role and future perspectives.干细胞衍生的细胞外囊泡作为再生医学的新工具 - 免疫调节作用和未来展望。
Front Immunol. 2023 Jan 24;14:1120175. doi: 10.3389/fimmu.2023.1120175. eCollection 2023.
4
Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies.干细胞细胞外囊泡作为抗 SARS-CoV-2 免疫调节治疗剂:临床前和临床研究的系统评价。
Stem Cell Rev Rep. 2024 May;20(4):900-930. doi: 10.1007/s12015-023-10675-2. Epub 2024 Feb 23.
5
Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges.干细胞衍生的细胞外囊泡:在致癌过程中的作用、生物工程潜力和技术挑战。
Stem Cell Res Ther. 2019 Nov 26;10(1):347. doi: 10.1186/s13287-019-1468-6.
6
Versatility of mesenchymal stem cell-derived extracellular vesicles in tissue repair and regenerative applications.间充质干细胞衍生的细胞外囊泡在组织修复和再生应用中的多功能性。
Biochimie. 2023 Apr;207:33-48. doi: 10.1016/j.biochi.2022.11.011. Epub 2022 Nov 23.
7
Extracellular Vesicles from Urine-Derived Stem Cell for Tissue Engineering and Regenerative Medicine.尿液来源的干细胞外泌体在组织工程和再生医学中的应用。
Tissue Eng Part B Rev. 2024 Apr;30(2):176-197. doi: 10.1089/ten.TEB.2023.0100. Epub 2023 Sep 22.
8
The Protein Content of Extracellular Vesicles Derived from Expanded Human Umbilical Cord Blood-Derived CD133 and Human Bone Marrow-Derived Mesenchymal Stem Cells Partially Explains Why both Sources are Advantageous for Regenerative Medicine.来自扩增的人脐血源性 CD133 和人骨髓源性间充质干细胞的细胞外囊泡的蛋白质含量部分解释了为什么这两种来源都有利于再生医学。
Stem Cell Rev Rep. 2017 Apr;13(2):244-257. doi: 10.1007/s12015-016-9715-z.
9
Stem Cell-Derived Extracellular Vesicles and Kidney Regeneration.干细胞衍生的细胞外囊泡与肾脏再生。
Cells. 2019 Oct 11;8(10):1240. doi: 10.3390/cells8101240.
10
Applications of Stem Cell-Derived Extracellular Vesicles in Nerve Regeneration.干细胞衍生的细胞外囊泡在神经再生中的应用。
Int J Mol Sci. 2024 May 28;25(11):5863. doi: 10.3390/ijms25115863.

引用本文的文献

1
Extracellular Vesicle-Integrated Biomaterials in Bone Tissue Engineering Applications: Current Progress and Future Perspectives.骨组织工程应用中细胞外囊泡整合生物材料:当前进展与未来展望
Int J Nanomedicine. 2025 Jun 17;20:7653-7683. doi: 10.2147/IJN.S522198. eCollection 2025.
2
Engineered extracellular vesicles derived from pluripotent stem cells: a cell-free approach to regenerative medicine.源自多能干细胞的工程化细胞外囊泡:再生医学的无细胞方法
Burns Trauma. 2025 Feb 11;13:tkaf013. doi: 10.1093/burnst/tkaf013. eCollection 2025.
3
Extracellular Vesicles in Sport Horses: Potential Biomarkers and Modulators of Exercise Adaptation and Therapeutics.

本文引用的文献

1
Substantial Overview on Mesenchymal Stem Cell Biological and Physical Properties as an Opportunity in Translational Medicine.间质干细胞的生物学和物理特性概述及其在转化医学中的机遇。
Int J Mol Sci. 2019 Oct 29;20(21):5386. doi: 10.3390/ijms20215386.
2
Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?间充质干细胞治疗伴侣动物:对免疫介导性疾病有效吗?
BMC Vet Res. 2019 Oct 22;15(1):358. doi: 10.1186/s12917-019-2087-2.
3
Heterologous and cross-species tropism of cancer-derived extracellular vesicles.
运动马匹中的细胞外囊泡:运动适应与治疗的潜在生物标志物和调节剂
Int J Mol Sci. 2025 May 3;26(9):4359. doi: 10.3390/ijms26094359.
4
Revealing the Therapeutic Potential of Stem Cells in Burn Healing: A Deeper Understanding of the Therapeutic Mechanisms of Epidermal Stem Cells and Mesenchymal Stem Cells.揭示干细胞在烧伤愈合中的治疗潜力:深入了解表皮干细胞和间充质干细胞的治疗机制
Stem Cells Int. 2024 Dec 16;2024:1914585. doi: 10.1155/2024/1914585. eCollection 2024.
5
Paraoxonase-1 Is a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation Through Adipose Stem Cell-Derived Extracellular Vesicles.对氧磷酶-1是一种关键调节因子,负责通过脂肪干细胞衍生的细胞外囊泡抑制过敏性气道炎症。
Int J Mol Sci. 2024 Nov 27;25(23):12756. doi: 10.3390/ijms252312756.
6
Exosomes derived stem cells as a modern therapeutic approach for skin rejuvenation and hair regrowth.源自干细胞的外泌体作为一种用于皮肤年轻化和头发生长的现代治疗方法。
Regen Ther. 2024 Nov 19;26:1124-1137. doi: 10.1016/j.reth.2024.10.001. eCollection 2024 Jun.
7
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.外泌体与癌症干细胞(CSCs)的治疗组合以及癌症治疗中癌症干细胞衍生外泌体(CSCEXs)的治疗组合。
Cancer Cell Int. 2024 Oct 5;24(1):334. doi: 10.1186/s12935-024-03514-y.
8
Application of Mesenchymal Stem Cells in Female Infertility Treatment: Protocols and Preliminary Results.间充质干细胞在女性不孕症治疗中的应用:方案与初步结果。
Life (Basel). 2024 Sep 13;14(9):1161. doi: 10.3390/life14091161.
9
Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery.基于间充质干细胞的药物递送的当前策略与治疗应用
Pharmaceuticals (Basel). 2024 May 30;17(6):707. doi: 10.3390/ph17060707.
10
SCGB1C1 Plays a Critical Role in Suppression of Allergic Airway Inflammation through the Induction of Regulatory T Cell Expansion.SCGB1C1 通过诱导调节性 T 细胞扩增在抑制过敏性气道炎症中发挥关键作用。
Int J Mol Sci. 2024 Jun 6;25(11):6282. doi: 10.3390/ijms25116282.
癌症衍生细胞外囊泡的异源和跨物种趋向性。
Theranostics. 2019 Aug 9;9(19):5681-5693. doi: 10.7150/thno.34824. eCollection 2019.
4
Optimizing oncolytic virotherapy in cancer treatment.优化溶瘤病毒治疗癌症。
Nat Rev Drug Discov. 2019 Sep;18(9):689-706. doi: 10.1038/s41573-019-0029-0. Epub 2019 Jul 10.
5
Biodistribution of gadolinium- and near infrared-labeled human umbilical cord mesenchymal stromal cell-derived exosomes in tumor bearing mice.钆和近红外标记的人脐带间充质基质细胞衍生的外泌体在荷瘤小鼠中的生物分布。
Theranostics. 2019 Apr 12;9(8):2325-2345. doi: 10.7150/thno.30030. eCollection 2019.
6
Advances in therapeutic applications of extracellular vesicles.细胞外囊泡治疗应用的新进展。
Sci Transl Med. 2019 May 15;11(492). doi: 10.1126/scitranslmed.aav8521.
7
Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges.间充质干细胞在血液恶性肿瘤抑制或进展中的作用:现状与挑战。
Leukemia. 2019 Mar;33(3):597-611. doi: 10.1038/s41375-018-0373-9. Epub 2019 Jan 31.
8
Engineered Exosome-Mediated Near-Infrared-II Region VC Quantum Dot Delivery for Nucleus-Target Low-Temperature Photothermal Therapy.工程化外泌体介导的近红外二区 VC 量子点递药用于细胞核靶向低温光热治疗。
ACS Nano. 2019 Feb 26;13(2):1499-1510. doi: 10.1021/acsnano.8b07224. Epub 2019 Jan 29.
9
Exosomes from human umbilical cord mesenchymal stem cells enhance fracture healing through HIF-1α-mediated promotion of angiogenesis in a rat model of stabilized fracture.人脐带间充质干细胞来源的外泌体通过 HIF-1α 介导促进血管生成增强稳定骨折大鼠模型中的骨折愈合。
Cell Prolif. 2019 Mar;52(2):e12570. doi: 10.1111/cpr.12570. Epub 2019 Jan 20.
10
Exosomes Derived From Mesenchymal Stem Cells Modulate miR-126 to Ameliorate Hyperglycemia-Induced Retinal Inflammation Via Targeting HMGB1.间充质干细胞来源的外泌体通过靶向 HMGB1 调节 miR-126 减轻高血糖诱导的视网膜炎症。
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):294-303. doi: 10.1167/iovs.18-25617.